Search for: "TRIS PHARMA, INC." Results 21 - 40 of 124
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
23 Jun 2009, 9:46 am
Here is IP Think Tank’s weekly selection of top Pharma & Biotech intellectual property news breaking in the blogosphere and internet. [read post]
9 Nov 2021, 5:04 pm by Ben Vernia
On November 9, the Department of Justice announced that Virginia-based pharmaceutical manufacturer Kaleo, Inc., has agreed to pay $12.7 million to settle fraud allegations, originally brought by a whistleblower, that the company steered physicians’ prescriptions to pharmacies kaléo Inc., a Virginia-based pharmaceutical manufacturer, has agreed to pay the United States $12.7 million to resolve allegations that kaléo caused the submission of false claims for… [read post]
9 Apr 2009, 7:52 am
(IP Think Tank) Brazilian public-private partnerships in the pharma industry (IP tango) EU: ECJ to rule on reference on SPC Regulation interpretation from Lithuania in Kirin Amgen, Inc. v Lietuvos Respublikos valstybinis patentų biuras (The SPC Blog) India: Delhi High Court Dasatinib order: Is patent-drug regulatory linkage a necessity? [read post]
15 Apr 2010, 4:27 am
Here is Think IP Strategy’s weekly selection of top Pharma & Biotech intellectual property news breaking in the blogosphere and internet. [read post]
22 Feb 2010, 6:07 am by Beck, et al.
In Goodridge v Pfizer Canada Inc., 2010 ONSC 1095 (Feb. 18, 2010), the plaintiffs claimed injuries from off-label use of Neurontin and its generic version. [read post]
3 Mar 2010, 5:05 am
Here is IP Think Tank’s weekly selection of top Pharma & Biotech intellectual property news breaking in the blogosphere and internet. [read post]
3 Mar 2010, 5:05 am
Here is IP Think Tank’s weekly selection of top Pharma & Biotech intellectual property news breaking in the blogosphere and internet. [read post]
8 Jul 2009, 7:04 am
Here is IP Think Tank’s weekly selection of top Pharma & Biotech intellectual property news breaking in the blogosphere and internet. [read post]
23 May 2022, 8:02 am by admin
” “The latest word from the Delaware court came Tuesday in Novartis’ bid to disqualify Chidambaram Iyer of Sughrue Mion PLLC from representing Shilpa Pharma Inc., the Pennsylvania arm of a generic drugmaker based in Raichur, India. [read post]
15 Apr 2009, 4:36 am
TRADEMARK ATTORNEY - NORTH SUBURBAN CHICAGO - McCormack Schreiber Legal Search Inc., Chicago, IL HEALTHCARE ETHICS/COMPLIANCE ATTORNEY - NORTH SUBURBAN CHICAGO - McCormack Schreiber Legal Search Inc., Chicago, IL INTELLECTUAL PROPERTY/TRADEMARK ATTORNEY - NORTH SUBURBAN CHICAGO - McCormack Schreiber Legal Search Inc., Chicago, IL HEALTHCARE COMPLIANCE ATTORNEY - LARGE PUBLIC COMPANY - McCormack Schreiber Legal Search Inc., Chicago, IL Corporate Counsel -… [read post]
14 Mar 2008, 4:20 am
This bill proves it.Yeah, we know, the "big bad Pharma" myth dies hard (since the other side does so much to perpetuate it), so we're going to have to give you better reasons than that.We will.Remember Medtronic, Inc. v. [read post]
20 Mar 2008, 10:01 pm
In one of its first kind of the judgment, the court tries to overcome the monopoly of Amgen that they had over Erythropoietin for Anemia associated with Chronic Kidney diseases. [read post]